Rep. Jefferson Shreve Sells Off Shares of Albemarle Co. (NYSE:ALB)

Representative Jefferson Shreve (R-Indiana) recently sold shares of Albemarle Co. (NYSE:ALB). In a filing disclosed on March 09th, the Representative disclosed that they had sold between $15,001 and $50,000 in Albemarle stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of Royal Gold (NASDAQ:RGLD) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of QUALCOMM (NASDAQ:QCOM) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of Pfizer (NYSE:PFE) on 2/24/2025.
• Sold $15,001 – $50,000 in shares of Norfolk Southern (NYSE:NSC) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of CoStar Group (NASDAQ:CSGP) on 2/24/2025.
• Purchased $50,001 – $100,000 in shares of AbbVie (NYSE:ABBV) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of The Cigna Group (NYSE:CI) on 2/24/2025.
• Purchased $15,001 – $50,000 in shares of Adobe (NASDAQ:ADBE) on 2/24/2025.

Albemarle Price Performance

Shares of ALB traded down $3.69 during trading hours on Tuesday, hitting $72.70. 2,582,014 shares of the company were exchanged, compared to its average volume of 2,667,656. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39. Albemarle Co. has a fifty-two week low of $67.23 and a fifty-two week high of $137.50. The company has a market cap of $8.55 billion, a price-to-earnings ratio of -6.49 and a beta of 1.70. The firm’s fifty day moving average is $83.73 and its 200 day moving average is $91.86.

Albemarle (NYSE:ALB) last announced its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. On average, equities analysts anticipate that Albemarle Co. will post -0.04 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th will be issued a $0.405 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.62 annualized dividend and a yield of 2.23%. Albemarle’s dividend payout ratio is presently -14.46%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ALB. Piper Sandler decreased their target price on Albemarle from $90.00 to $85.00 and set an “underweight” rating on the stock in a research report on Thursday, February 20th. Royal Bank of Canada lowered their price objective on shares of Albemarle from $133.00 to $114.00 and set an “overweight” rating for the company in a research report on Wednesday, February 12th. Clarkson Capital began coverage on shares of Albemarle in a research report on Tuesday, January 14th. They issued a “buy” rating and a $112.00 target price on the stock. Robert W. Baird decreased their target price on shares of Albemarle from $103.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 12th. Finally, Morgan Stanley dropped their price target on Albemarle from $73.00 to $68.00 and set an “underweight” rating for the company in a research note on Tuesday, February 18th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Albemarle has an average rating of “Hold” and a consensus price target of $107.05.

Institutional Investors Weigh In On Albemarle

Several institutional investors and hedge funds have recently made changes to their positions in the business. Quarry LP lifted its stake in Albemarle by 1,400.0% in the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock valued at $26,000 after buying an additional 252 shares during the period. Assetmark Inc. lifted its position in shares of Albemarle by 340.6% during the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 235 shares during the period. Trust Co. of Vermont boosted its stake in Albemarle by 606.5% during the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 279 shares in the last quarter. First Community Trust NA grew its holdings in Albemarle by 55.0% in the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 142 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in Albemarle in the fourth quarter valued at $34,000. Institutional investors own 92.87% of the company’s stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.